ÂÜÀòÂÒÂ×

Zammany Kline has a solid work experience in the field of Drug Metabolism and Pharmacokinetics (DMPK). Zammany currently serves as a Senior Scientist, DMPK at Genesis Therapeutics since March 2023. Prior to that, they worked at Turning Point Therapeutics as a Scientist, DMPK from May 2021 to February 2023.

Zammany has also gained valuable experience at Ferring Pharmaceuticals, where they held the position of Sr. Research Associate DMPK from August 2015 to May 2021. In this role, they were responsible for leading pharmacokinetic (PK) studies on various projects, designing studies, analyzing data, and reporting findings to the team. Zammany also collaborated with Contract Research Organizations (CROs) to outsource studies and developed in-house DMPK assays for small molecule compounds.

Before joining Ferring Pharmaceuticals, Zammany worked as a Research Associate DMPK at Celgene from October 2013 to September 2015.

Zammany began their career as an Analytical Scientist at Phamatech, Inc in June 2010. During their tenure there, they supervised the Confirmations department of the laboratory and conducted drug extractions using various techniques. Zammany also utilized analytical software and instruments such as GC/MS and LC/MS/MS for sample analysis.

Overall, Zammany Kline has gained extensive experience in DMPK, including study design, data analysis, collaboration with CROs, and assay development.

Zammany Kline completed a Bachelor of Science in Biology at Centenary University in 2005. After that, they pursued a Master of Forensic Science with a specialization in criminalistics at National University, which they completed in 2020.